ABEO
NASDAQ · Biotechnology
Abeona Therapeutics Inc
$7.46
+0.06 (+0.81%)
Open$7.40
Previous Close$7.40
Day High$7.55
Day Low$7.31
52W High$7.54
52W Low$4.00
Volume—
Avg Volume972.9K
Market Cap408.66M
P/E Ratio6.18
EPS$0.87
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+88.9% upside
Current
$7.46
$7.46
Target
$14.09
$14.09
$7.81
$14.09 avg
$15.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.60M | 3.49M | 39.71M |
| Net Income | 68.51M | 38.44M | -4,431,314 |
| Profit Margin | 1,223.1% | 1,161.9% | -11.2% |
| EBITDA | 63.01M | 37.32M | -4,969,444 |
| Free Cash Flow | — | — | -4,447,710 |
| Rev Growth | +60.4% | +60.4% | +12.5% |
| Debt/Equity | 0.13 | 0.13 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |